Home › Major Depressive Disorder › Ohio › Parma
Major Depressive Disorder clinical trials in Parma, OH
5 studies for Major Depressive Disorder are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
- Neurocrine Clinical Site, Independence · 5 mi away
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RecruitingPhase 2
- Seaport Investigator Site, Independence · 5 mi away
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RecruitingPhase 3
- Insight Clinical Trials, Independence · 5 mi away
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
RecruitingPhase 2
- Insight Clinical Trials LLC, Independence · 5 mi away
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
RecruitingPhase 2
- Insight Clinical Trials LLC, Independence · 5 mi away
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA30 studies
- Atlanta, GA24 studies
- Philadelphia, PA22 studies
- Orlando, FL19 studies
- Tampa, FL17 studies
- Miami, FL17 studies
- Chicago, IL16 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Parma
- Ulcerative Colitis10 studies
- Steatotic Liver Disease7 studies
- Crohn's Disease7 studies
- Psoriatic Arthritis6 studies
- Lung Cancer5 studies
- Schizophrenia5 studies
- Endometrial Cancer5 studies
- Non-Small Cell Lung Cancer4 studies
- Cancer (all types)4 studies
- Ovarian Cancer4 studies
- Alzheimer's Disease4 studies
- Psychotic Disorders4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.